BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8549386)

  • 21. Cefixime therapy for otitis media.
    Hefelfinger DC
    Pediatr Infect Dis J; 1993 Aug; 12(8):703-5. PubMed ID: 8414791
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
    Grassi C; Salvatori E; Rosignoli MT; Dionisio P;
    Respiration; 2002; 69(3):217-22. PubMed ID: 12097764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of lower respiratory tract infections including pneumonia. Comparative study with i.vl cefotaxime/oral cefixime versus parenteral cefotaxime].
    Vogel F
    Fortschr Med; 1994 Oct; 112(28):395-8. PubMed ID: 7988978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of severe cefixime-induced diarrhea.
    Gales MA; Gales BJ
    Clin Pharm; 1993 Dec; 12(12):881. PubMed ID: 8137604
    [No Abstract]   [Full Text] [Related]  

  • 25. Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year.
    Torrance G; Walker V; Grossman R; Mukherjee J; Vaughan D; La Forge J; Lampron N
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):499-520. PubMed ID: 10662396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
    Brückner O; Trautmann M
    J Chemother; 1989 Jul; 1(4 Suppl):782-3. PubMed ID: 16312637
    [No Abstract]   [Full Text] [Related]  

  • 27. The quinolones in chronic bronchitis.
    Davies BI; Maesen FP; Teengs JP; Baur C
    Pharm Weekbl Sci; 1986 Feb; 8(1):53-9. PubMed ID: 3960693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefixime therapy for otitis media.
    Friedland IR
    Pediatr Infect Dis J; 1993 Jun; 12(6):544-5. PubMed ID: 8345993
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anaphylaxis caused by cefixime with tolerance to other beta lactams].
    Vilas Martínez F; Joral A; Garmendia JF; Villarreal O
    Med Clin (Barc); 1996 Mar; 106(11):439. PubMed ID: 8637300
    [No Abstract]   [Full Text] [Related]  

  • 30. [Reducing the severity of otitis media and acute bronchitis].
    Nurs Que; 1990; 10(3):22. PubMed ID: 2333171
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute exacerbations of chronic bronchitis: a pharmacoeconomic review of antibacterial use.
    Morris S; Anderson P; Irwin DE
    Pharmacoeconomics; 2002; 20(3):153-68. PubMed ID: 11929346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ciprofloxacin--a highly effective drug from the fluoroquinolone group].
    Iakovlev VP
    Antibiot Khimioter; 1997; 42(6):4-14. PubMed ID: 9313059
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cefixime. Clinical and microbiological examination].
    Infection; 1990; 18 Suppl 3():S113-70. PubMed ID: 2079367
    [No Abstract]   [Full Text] [Related]  

  • 34. [Epidemiology, bacteriology and clinical experience with cefixime in the treatment of acute infantile otitis media].
    Charles D; Bluestone MD
    An Esp Pediatr; 1991 Dec; 35 Suppl 46():101-4. PubMed ID: 1821523
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
    Asmar BI; Dajani AS; Del Beccaro MA; Mendelman PM
    Pediatrics; 1994 Dec; 94(6 Pt 1):847-52. PubMed ID: 7971000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Increasing incidence of ciprofloxacin resistant gonorrhea in Sweden. Choose a correct antibiotic and follow up the treatment!].
    Berglund T; Colucci B; Lund B; Qvarnström I; Sandström E
    Lakartidningen; 2004 Jul; 101(28-29):2332-5. PubMed ID: 15291311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute exacerbations of chronic bronchitis. Preventing treatment failures and early reinfection.
    Verghese A; Ismail HM
    Postgrad Med; 1994 Dec; 96(8):75-6, 79-82, 87-9. PubMed ID: 7991479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Do tendon lesions occur during quinolone administration?].
    Shah P
    Dtsch Med Wochenschr; 2003 Oct; 128(42):2214. PubMed ID: 14562223
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections.
    LeFrock JL; Molavi A; Lentnek AL; Rolston KV; Chandrasekar PH; Smith BR; Kannangara W; Schell RF; Oaks SS; Carr BB
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():215-21. PubMed ID: 6296009
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines.
    Aplasca De Los Reyes MR; Pato-Mesola V; Klausner JD; Manalastas R; Wi T; Tuazon CU; Dallabetta G; Whittington WL; Holmes KK
    Clin Infect Dis; 2001 May; 32(9):1313-8. PubMed ID: 11303266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.